Takeda Pharmaceutical Company Limited
Recombinant VWF formulations
Last updated:
Abstract:
The present invention provides long-term stable pharmaceutical formulations of recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
Status:
Grant
Type:
Utility
Filling date:
22 Apr 2015
Issue date:
7 Dec 2021